ICON plc - ADR

$169.31

up-down-arrow $3.62 (2.18%)

As on 11-Sep-2026 16:00EDT

Market cap

info icon

$12,719 Mln

Revenue (TTM)

info icon

$8,330 Mln

P/E Ratio

info icon

249.8

P/B Ratio

info icon

1.3

Div. Yield

info icon

0 %

Value Research Rating

--

Quality Score fund-quick-summary-circle

Quality Score/10

Growth Score fund-quick-summary-circle

Growth Score/10

Valuation Score fund-quick-summary-circle

Valuation Score/10

Momentum Score fund-quick-summary-circle

Momentum Score/10

ICON - ADR Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 165.68 High: 175.63

52 Week Range

Low: 66.57 High: 203.91

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    0 %

  • ROCEROCE information

    1.8 %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    22.4

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $0.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    77,154,209

10 Years Aggregate

CFO

$4,582.19 Mln

EBITDA

$6,817.54 Mln

Net Profit

$3,242.57 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
ICON - ADR
-7.1 2.0 17.1 2.3 -12.2 -8.1 8.5
BSE Sensex
-11.7 -4.8 1.1 -8.2 3.9 5.1 10.0
As on 11-Sep-2026
Company
2025
2023
2022
2021
2020
2019
ICON - ADR
-13.1 45.7 -37.3 58.8 13.2 33.3
BSE Sensex
9.1 18.7 4.4 22.0 15.8 14.4
BSE Sensex
9.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About ICON - ADR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development,...  management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland. 

  • Founder & Independent Non-Executive Director

    Dr. John Climax Ph.D.

  • Founder & Independent Non-Executive Director

    Dr. John Climax Ph.D.

  • Headquarters

    Dublin

  • Website

    https://www.iconplc.com

FAQs for ICON - ADR

The share price of ICON plc - ADR is $169.31 (NASDAQ) as of 11-Sep-2026 16:00 EDT. ICON plc - ADR has given a return of -12.2% in the last 3 years.

The P/E ratio of ICON plc - ADR is 249.77 times as on 04-Sep-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
60.84
1.52
2024
21.79
1.81
2023
38.42
2.55
2022
31.70
1.88
2021
167.46
3.18

The 52-week high and low of ICON plc - ADR are Rs 203.91 and Rs 66.57 as of 12-Sep-2026.

ICON plc - ADR has a market capitalisation of $ 12,719 Mln as on 04-Sep-2026. As per SEBI classification, it is a company.

Before investing in ICON plc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...